Inaktiver Wert

Andere Sprachen Axovant Sciences Ltd Nyse

Aktien

AXON

BMG0750W1047

AXON

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	02.02.
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	02.02.
SIO GENE THERAPIES INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	06.04.23
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index	27.03.23
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index	22.03.23
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	15.03.23
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	15.03.23
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	14.02.23
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14.02.23
Sio Gene Therapies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14.02.23
Sio Gene Therapies Board Approves Plan of Liquidation, Dissolution; Shares Rise After Hours	14.12.22
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution	14.12.22
Sio Gene Therapies : Announces Board Approval of Plan of Complete Liquidation and Dissolution - Form 8-K	14.12.22
SIO GENE THERAPIES INC. : Other Events, Financial Statements and Exhibits (form 8-K)	14.12.22
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10.11.22
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10.11.22
Sio Gene Therapies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10.11.22
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results	10.11.22
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	14.09.22
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	14.09.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Axovant Sciences Ltd Nyse

Aktien

AXON

BMG0750W1047

AXON

Andere Sprachen

Filter